Ad
related to: drugmaker celgene
Search results
Bristol Myers must face $6.4 billion lawsuit over delayed cancer drug
Reuters via Yahoo Finance· 2 years agoA U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of...
This Unpopular Dividend Stock Is a Buy
Motley Fool via Yahoo Finance· 4 days agoDividend stocks are an important anchor for well-balanced portfolios. Regular cash distributions can buffer a portfolio against market volatility and...
UPDATE 1-GSK's blood cancer drug fails main goal of superiority trial
Reuters via Yahoo Finance· 2 years agoBritish drugmaker GSK Plc said on Monday its blood cancer drug Blenrep failed the main goal of a late-stage study designed to show that the treatment was better than the standard of care on ...
How These Acquisitions Are Changing the Outlook for Bristol Myers Squibb
Motley Fool· 2 years agoPharmaceutical giant Bristol Myers Squibb's (NYSE: BMY) purchase of Celgene turned it into a dominant player in oncology and hematology, and this year, the company has aggressively strengthened ...
Viatris names Scott Smith as CEO ahead of planned divestiture of certain businesses
Reuters via Yahoo Finance· 1 year agoFeb 27 (Reuters) - Viatris Inc said on Monday it has appointed Scott Smith as chief executive officer, effective April 1, as the drugmaker prepares to divest some of its non-core businesses ...
Bristol Myers Squibb Is a Must-Own Stock Right Now. Here's Why.
Motley Fool· 2 years agoThe 2022 bear market has been a sight to behold. The benchmark S&P 500, which is widely viewed as a...
New U.S. cancer drug prices rise 53% in five years -report
Reuters via Yahoo News· 2 years agoThe annual price of a newly-launched cancer drug in the United States averaged $283,000 last year, a...
Is Bristol Myers Squibb a Top Dividend Stock?
Motley Fool· 12 months agoBristol Myers Squibb (BMS) (NYSE: BMY), a multinational pharmaceutical company, has all the hallmarks of a top-shelf dividend stock. The company has...
Bristol Myers' bowel disease drug fails in late-stage study
Reuters via Yahoo News· 2 months agoCrohn's is a chronic bowel disease that causes inflammation in the digestive tract, and can lead to...
Former Bristol Myers CEO tapped as Novartis’ next board chair
BioPharma Dive via Yahoo Finance· 1 month agoGiovanni Caforio, who left Bristol Myers in November after eight years as CEO, is set to succeed...
